India has faltered at multiple levels in the rollout of its vaccination programme. As a result, the pace is much lower than desired. Bharat Biotech, for instance, on Tuesday said the government’s procurement price at Rs 150 per dose for Covaxin was not sustainable in the long run. This effectively means that the firm has little or no incentive to increase production, which can directly affect the vaccine rollout. In this context our lead editorial
argues that India’s covid-19 vaccination programme should not suffer because of less-than- adequate planning. Read here
Efforts by India to get back Mehul Choksi
will depend to a large extent on the response to the request for his repatriation from Dominica. The problem however is compounded by the fact that Dominica does not figure in the list of countries with which India has an extradition treaty or arrangement, writes Shyamal Majumdar
A deeper integration with East Asian economies could be integral to India’s economic recovery in the pandemic, writes Amita Batra
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.